Manus Neurodynamica

Manus Neurodynamica Ltd specializes in creating medical devices for assessing neuromotor conditions.Manus Neurodynamica specializes in the development of the NeuroMotor Pen™, a non-invasive, patented medical device designed to aid in the diagnosis and monitoring of neuromotor impairments, particularly Parkinson's disease and tremor disorders. The NeuroMotor Pen™ employs advanced sensor technologies and analytical software to evaluate fine motor skills through standardized handwriting and drawing tasks performed by patients on a high-end tablet. This technology quantifies limb and hand motion parameters, providing clinicians with clinically validated biomarkers that offer objective insights into movement abnormalities. The primary customers of Manus Neurodynamica include healthcare providers and specialists in neurology, general practitioners, and community health organizations across Europe.Manus Neurodynamica generates revenue primarily through direct sales of the NeuroMotor Pen™ to healthcare providers, which may involve partnerships with medical institutions and general practitioners. The company operates on a business-to-business model, providing its devices and associated software solutions to clinics and hospitals that manage patients with neuromotor disorders. The transactions typically encompass both the sale of the device and subscriptions for ongoing software support and data analytics services. This dual revenue stream enables clinicians to leverage the NeuroMotor Pen™ for differential diagnosis and treatment optimization. Future initiatives include the development of new products aimed at improving patient diagnostics and expanding their reach into additional European healthcare markets.

1. Seed

   May 27, 2020

   Amount

   $0.9M

   Investors

   Locked

2. Seed

   Oct 25, 2018

   Amount

   $0.9M

   Investors

   Locked